Insilico Medicine Launches AI Pilot, Gene Solutions Enters Turkey, and NIH Updates Workbench - Life AI Weekly #57

March 04, 2026 - Life AI Weekly
Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in healthcare and life sciences AI. This week, the National Institutes of Health has enhanced its All of Us Researcher Workbench, providing improved tools for data exploration to over 21,500 researchers. Meanwhile, Milliman MedInsight has appointed Iyibo Jack as the new Chief Product Officer, focusing on driving AI innovation in healthcare analytics.

In other news, DentScribe has received a U.S. patent for its AI system that automates clinical documentation in dentistry, and Procode AI has launched with $4 million in funding, acquiring The Auctus Group to enhance billing processes for surgeons. Additionally, Senhwa Biosciences and CellType have partnered to develop next-generation immunotherapy using AI technology. Stay tuned as we explore these stories and more in this edition.
NIH Updates All of Us Researcher Workbench
The National Institutes of Health's All of Us Research Program has updated its Researcher Workbench platform, enhancing tools for data exploration and analysis for over 21,500 registered researchers. Read more
Milliman MedInsight Appoints New Chief Product Officer
Milliman MedInsight has appointed Iyibo Jack as Chief Product Officer to lead AI innovation in healthcare analytics, succeeding Rich Moyer. Read more
DentScribe Receives U.S. Patent for AI Documentation System
DentScribe has been granted its first U.S. patent for a system that automates clinical documentation in dentistry, aiming to convert conversations into structured records. Read more
Procode AI Launches with $4M Funding and Acquisition
Procode AI, an AI-driven revenue cycle management company, has launched with $4 million in funding and acquired The Auctus Group to enhance billing processes for surgeons. Read more
Turbine Raises $25M and Partners with Pharma Giant
Turbine, a virtual biology company, has secured $25 million in Series B funding led by Interactive Venture Partners and announced a new immunology partnership with a top 10 pharmaceutical company. Read more
Insilico Medicine Launches AI Partnering System Pilot
Insilico Medicine has initiated a pilot for its Automated AI-Driven Partnering System, designed to streamline business development in biotechnology by automating due diligence and data management processes. Read more
Senhwa and CellType Collaborate on CX-4945 Immunotherapy
Senhwa Biosciences has partnered with CellType to develop CX-4945 into a next-generation immunotherapy using AI technology. Read more
Grow Therapy Secures $150 Million in Series D Funding
Grow Therapy has raised $150 million in Series D funding, increasing its valuation to $3 billion. The investment aims to support the company's AI-driven mental health solutions and expand its service reach. Read more
Gene Solutions Enters Turkish Market with AI Cancer Detection
Gene Solutions has announced its expansion into Türkiye, presenting AI-powered cancer detection solutions at the 2nd International Hereditary Cancers Congress 2026 in Antalya. Read more
Liquid AI and Insilico Medicine Partner for Drug Discovery Models
Liquid AI and Insilico Medicine have announced a partnership to develop lightweight scientific foundation models for drug discovery, including the LFM2-2.6B-MMAI model, which excels in various tasks while operating on private pharmaceutical infrastructure. Read more
Perimeter Medical's AI Device for Breast Cancer Surgery Approved by FDA
Perimeter Medical Imaging AI, Inc. has received FDA premarket approval for Claire™, marking it as the first AI-enabled imaging device for breast cancer surgery in the U.S. The device aims to improve surgical outcomes with an 88.1% margin accuracy. Read more
Delphyr Raises €1.75 Million for AI in Healthcare
Delphyr, a Dutch AI platform, has secured €1.75 million in funding to integrate AI agents into healthcare systems, aiming to reduce administrative tasks for professionals. Read more
Ease Health Raises $41M for AI Operating System
Ease Health has secured $41 million in Series A funding from Andreessen Horowitz to develop an AI-native operating system for behavioral health providers. Read more
Third Way Health Raises $15 Million for AI Healthcare Operations
Third Way Health has secured $15 million in Series A funding from Health Velocity Capital to expand its AI capabilities and operational scale in healthcare. The company aims to address administrative challenges and improve patient care with its hybrid human and AI solutions. Read more
Droplet Biosciences Enhances Cancer Detection with NVIDIA AI
Droplet Biosciences has improved cancer detection speed by using NVIDIA AI infrastructure. Their LymphDetect™ test now provides faster genomic analysis, enhancing patient care. Read more
SciBase's Nevisense Gains FDA Approval for Broader Use
The FDA has approved SciBase to expand the use of its AI diagnostic tool Nevisense, allowing more healthcare professionals to perform the procedure, enhancing clinic integration and patient access. Read more
DarcyIQ Integrates with Epic and athenahealth
DarcyIQ has announced its integration with Epic and athenahealth to enhance AI-driven healthcare workflows. This integration aims to streamline clinical and operational processes by allowing natural language access to patient records and administrative tasks. Read more
Elsevier Introduces Osmosis AI for Medical Students
On March 3, 2026, Elsevier announced the launch of Osmosis AI, a study tool for medical students that combines AI-driven conversation with visual learning resources, aligned with USMLE content. Read more
Guideway Care Acquires Waypoint Healthcare Solutions
On March 3, 2026, Guideway Care announced its acquisition of Waypoint Healthcare Solutions to enhance its AI-driven patient activation solutions. Read more
Antiverse Secures $9.3M in Series A Funding
UK-based biotech firm Antiverse has raised $9.3 million in a Series A funding round led by Soulmates Ventures to enhance its AI-driven antibody discovery platform. Read more
Harrison.ai Seeks FDA Exemption for AI Devices
The Australia-based firm Harrison.ai has requested the FDA to exempt certain radiology AI devices from premarket review, citing regulatory barriers to innovation. The FDA is evaluating the request amidst mixed industry reactions. Read more
DentScribe Expands AI Platform for Dentistry
DentScribe has announced an expansion of its AI platform to improve clinical documentation and operational efficiency in dentistry. The platform converts conversations into structured notes and integrates them into management systems. Read more
Qura Secures €1.5 Million in Pre-Seed Funding
Italian health-tech platform Qura has raised €1.5 million in a pre-seed funding round led by United Ventures to enhance its AI-driven preventative health services. Read more
Lyfegen Unveils AI Tool for Drug Pricing
On March 3, 2026, Lyfegen launched its AI Contracting Companion to aid pharmaceutical companies in managing drug pricing and contracting complexities. The tool was introduced at the World Evidence, Pricing and Access Congress in Amsterdam. Read more

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.